Steve Gavel

Steve Gavel serves as the Chief Commercial Officer at Orca Bio since June 2025 and is a Managing Partner at Celiance Consulting, a firm specializing in the commercialization of cell and gene therapies. Prior experience includes serving as Senior Vice President for Global Cell Therapy Commercial Development at Legend Biotech, where responsibilities included leading the commercial development of a Multiple Myeloma candidate and overseeing co-development activities with Janssen. Gavel's tenure at Celgene included roles as CAR-T US Commercial Development Lead, focusing on the launch strategy for bb2121, and as Executive Director for US Commercial Strategy in the Hematology/Oncology portfolio. Gavel holds a BS in Finance and Business Administration from Millersville University of Pennsylvania.